2024 Specialty Pharmacies Vaccines 
Drug Topics
JULY 11, 2025
In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. Of those, 38% had evidence of pneumococcal vaccination prior to January 2022.
Drug Topics
AUGUST 12, 2025
Partnerships between community pharmacists and local primary care providers can help increase the uptake of respiratory syncytial virus (RSV) vaccines, according to recent data published in the journal JAPhA Practice Innovations. Prevention of the disease was previously limited to palivizumab, a costly antibody.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 6, 2025
Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.
Drug Topics
JUNE 20, 2025
Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations. This abrupt change has raised significant concerns within the health care community about the potential impact on vaccine trust and public health policy.
Pharmacy Times
AUGUST 6, 2025
Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates. Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates.
Pharmacy Times
AUGUST 12, 2025
The vaccine showed superior immune response for unique serotypes compared to PPSV23, with higher OPA titers. Insights from the Japanese study can inform global pneumococcal vaccination strategies for older adults at increased risk. 1 Older adults are at increased risk of invasive pneumococcal disease.
Drug Topics
JUNE 20, 2025
With significant progress made in researchers’ understanding of dermatological diseases, a pathway has been made for the development of targeted vaccines, according to data published in Vaccines. 5 Throughout the past 10 years, development of vaccines for preventing skin diseases has made significant progress.
Expert insights. Personalized for you.
Let's personalize your content